Mutares Keeps Both Hands Busy: Divestitures and Deal-Making Revive the Case for the Stock
17.06.2026 - 07:15:17 | boerse-global.de
Mutares has long played the role of the market’s misunderstood value play, but the Munich-based turnaround specialist is now giving investors two distinct reasons to reconsider. On one side, it is briskly monetising past acquisitions – the latest being the sale of its Romanian Walor Precision Turning plant to Reed Capital. On the other, it is doubling down on new bets, with the planned purchase of MAFI Transport-Systeme and TREPEL Airport Equipment now formally filed with Germany’s cartel office. The combination of cash-releasing exits and pipeline-building buys is providing the clearest signal yet that management’s buy-fix-sell engine is running at full throttle.
The MAFI-TREPEL deal, which involves taking over both companies from NDW Maschinenbau Holding, adds roughly 410 employees and a combined annual turnover of around €150 million to Mutares’ infrastructure and special industries segment. TREPEL manufactures aircraft tugs and high-loaders for aviation, while MAFI supplies heavy-duty tractors for ports and logistics hubs. The transaction is expected to close in the third quarter, pending the green light from the competition authorities. For a group that posted group-wide revenues of nearly €1.7 billion in the first quarter – a 10% year-on-year increase – these additions are meaningful but manageable bolt-ons that fit the existing portfolio logic.
Yet the headline numbers on the holding level tell a more sober story. Mutares booked a net loss of €0.9 million in the first quarter, a sharp reversal from the €29.5 million profit recorded a year earlier. The swing reflects the lumpy nature of the restructuring business, where holding costs can temporarily outpace earnings from subsidiaries. Management, however, has held firm on its full-year guidance and long-term targets out to 2030, arguing that the underlying portfolio is generating cash and operational improvements even as the parent company’s accounts show a loss.
Should investors sell immediately? Or is it worth buying Mutares?
At the equity level, the discrepancy between operational progress and market sentiment is hard to ignore. The stock trades at the lowest price-to-earnings ratio in the entire SDAX index while simultaneously offering the highest dividend yield in the same universe. With a market capitalisation of roughly €626 million, the shares are pricing in a significant risk discount – a gap that some analysts believe is starting to close. The current price of around €29 represents a 21% discount to the 52-week high of €36.75, and the stock has clawed back about 8-9% over the past month, hinting that buyers are gradually emerging.
Technically, the picture has brightened considerably. The share has already cleared its short- and medium-term moving averages and is now wrestling with the 200-day line at €28.98. A sustained break above that threshold would generate a powerful buy signal. The relative strength index, at roughly 63, indicates room to run without entering overbought territory. Moreover, the stock is now more than 9% above its 50-day moving average, reinforcing the view that the downtrend that pushed the stock down nearly 16% over the past twelve months may have finally run its course.
For now, Mutares remains a bet on management’s dealmaking finesse. The Walor exit adds another data point to a track record of turning around underperformers and selling them at a profit, while the MAFI and TREPEL acquisitions show that the pipeline for new turnarounds remains full. With the cartel decision expected in the coming weeks and the stock flirting with a key technical breakout, the pieces are falling into place for a rerating. The risk lies in execution – integrating new subsidiaries quickly and repeating the margin improvements that have made the model work. But as long as both the exit motor and the acquisition engine keep humming, the downside from current levels looks increasingly capped.
Ad
Mutares Stock: New Analysis - 17 June
Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
